Visionary Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.
BiotechHealthtechMedical DevicesSeattle, US
DAVID ROSTOV(Executive Officer)inGREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)
Co-investorsDeerfield Management CompanyFlying L Partners
Vana is an open data infrastructure platform that enables individuals to control and manage the data they generate, with the ability to choose how it is used by AI systems.
AI & Machine LearningData & Infrastructure
Art Abal(Founder)
Co-investorsAbstract VenturesAlphaLab CapitalCaladanEarl Grey CapitalParadigmSCB 10X+7 more
Vana provides open data infrastructure for AI that lets individuals control the data they create and choose how it is used.
AI & Machine LearningCrypto & Web3Data & Infrastructure
Co-investorsFlori VenturesBoxGroupCoinbase VenturesDeFiance CapitalExSight VenturesGSR+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






